Blog

Comprehensive molecular profiling in lung cancer

AI Generated

Jan 21, 2025, 07:03

Comprehensive molecular profiling in lung cancer

Akhil Santhosh, Medical Oncologist at AIIMS Delhi, shared an article by Joshue E. Reuss et al. on X:

“Comprehensive molecular profiling of squamous non-small cell lung cancer reveals high incidence of actionable genomic alterations among patients with no history of smoking – Lung Cancer.

Should look out for MET and EGFR alterations.”

Comprehensive molecular profiling of squamous non-small cell lung cancer reveals high incidence of actionable genomic alterations among patients with no history of smoking

Authors: Joshua E. Reuss, Jacob Zaemes, Nishant Gandhi, Phillip Walker, Sandip P. Patel, Joanne Xiu, Charu Aggarwal, Ari Vanderwalde, Suresh S. Ramalingam, Balazs Halmos, Stephen V. Liu.

Comprehensive molecular profiling in lung cancer

cancer Dr. Akhil Santhosh EGFR alterations genomic alterations Lung cancer Lung Cancer Journal lung cancer research MET alterations molecular profiling non-smokers OncoDaily Oncology smoking history squamous non-small cell lung cancer targeted therapy

BEATcc Trial at ESMOGynaec25: Atezolizumab Benefits Cervical Cancer Patients Regardless of PD-L1 Status

15 Posts Not to Miss from EACR 2025

ASCO 2025 RCC Advances: Expert Insights by Ilya Tsimafeyeu

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine

Smoking and Bladder Cancer: What You Need to Know to Protect Yourself